Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Traeger
COOK
$172M
| $517K | ﹤0.01% |
1,390
+96
| +7% | +$45.8K |
|
|
VAPO
2602
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $514K | ﹤0.01% |
4,625
+362
| +8% | +$45.2K |
|
|
PYR
2603
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
| $508K | ﹤0.01% |
203,200
+21,200
| +12% | +$48.9K |
|
2604
TORM
TRMD
$2.97B
| $503K | ﹤0.01% |
58,020
+4,248
| +8% | +$33.5K |
|
|
INBX
2605
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $501K | ﹤0.01% |
22,500
+1,200
| +6% | +$30.6K |
|
2606
Viking Therapeutics
VKTX
$3.97B
| $500K | ﹤0.01% |
166,500
+11,200
| +7% | +$40.2K |
|
|
IGMS
2607
DELISTED
IGM Biosciences
IGMS
| $495K | ﹤0.01% |
18,500
+1,500
| +9% | +$27.9K |
|
2608
Erasca
ERAS
$6.45B
| $494K | ﹤0.01% |
57,400
+4,000
| +7% | +$46.3K |
|
2609
Spruce Power Holding Corp
SPRU
$38.9M
| $492K | ﹤0.01% |
30,913
+11,750
| +61% | +$205K |
|
2610
Rimini Street
RMNI
$445M
| $476K | ﹤0.01% |
82,100
+7,200
| +10% | +$37.8K |
|
|
LBC
2611
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $472K | ﹤0.01% |
35,500
| – | – |
|
2612
Vital Farms
VITL
$495M
| $471K | ﹤0.01% |
38,100
+2,400
| +7% | +$36K |
|
2613
Precigen
PGEN
$2.45B
| $464K | ﹤0.01% |
220,000
+14,700
| +7% | +$35.8K |
|
|
FXLV
2614
DELISTED
F45 Training Holdings Inc.
FXLV
| $458K | ﹤0.01% |
42,800
+3,000
| +8% | +$38.8K |
|
2615
Phathom Pharmaceuticals
PHAT
$742M
| $455K | ﹤0.01% |
33,400
+2,400
| +8% | +$38.8K |
|
|
BASE
2616
DELISTED
Couchbase
BASE
| $449K | ﹤0.01% |
25,800
+1,900
| +8% | +$38.5K |
|
2617
Cricut
CRCT
$1.23B
| $449K | ﹤0.01% |
34,300
+7,300
| +27% | +$126K |
|
2618
Donegal Group Class A
DGICA
$692M
| $449K | ﹤0.01% |
33,500
+3,100
| +10% | +$43.3K |
|
|
ALLK
2619
DELISTED
Allakos
ALLK
| $439K | ﹤0.01% |
77,100
+5,800
| +8% | +$37.5K |
|
|
MKFG
2620
DELISTED
Markforged Holding Corporation
MKFG
| $438K | ﹤0.01% |
10,980
+790
| +8% | +$34.6K |
|
|
HEXO
2621
DELISTED
HEXO Corp. Common Shares
HEXO
| $433K | ﹤0.01% |
50,264
+18,393
| +58% | +$157K |
|
2622
Vroom Inc
VRM
$52.1M
| $431K | ﹤0.01% |
2,024
+140
| +7% | +$66.4K |
|
|
WEBR
2623
DELISTED
Weber Inc.
WEBR
| $428K | ﹤0.01% |
43,500
+3,100
| +8% | +$33.4K |
|
2624
Cipher Digital
CIFR
$7.42B
| $424K | ﹤0.01% |
116,500
+7,700
| +7% | +$24.7K |
|
2625
Mission Produce
AVO
$1.13B
| $423K | ﹤0.01% |
33,400
+2,300
| +7% | +$30.6K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.